F18 pifluflostat (pylarify) radiopharmaceutical
Ended Awarded Last action
- Contract number
- 36C25724F0052
- Awardee
-
Progenics Pharmaceuticals Inc. UEI YLYKVRPCTCR3 Part of Lantheus Holdings, Inc.
- Awarding agency
-
Veterans Integrated Service Network 17
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $1,836,004
Award facts
- Contract value 100% obligated
- $1,836,003.60 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- North Billerica, Billerica, MA 01862, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | $147,949 | |
| Supplemental Agreement for work within scope | $144,349 | |
| Supplemental Agreement for work within scope | $10,000 | |
| Original award | $1,533,706 |
About this award
This federal contract award was issued by the Department of Veterans Affairs (VA) to Progenics Pharmaceuticals Inc., a division of Lantheus Medical Imaging, Inc. and subsidiary of Lantheus Holdings, Inc. The $1,836,003.60 firm fixed price delivery order is for the procurement of PYLARIFY (piflufolastat F-18), a radiopharmaceutical used in positron emission tomography (PET) scans to detect and image prostate cancer. This contract was awarded under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) and is not a set-aside for small businesses. Lantheus Holdings, Inc. maintains several indefinite delivery vehicles (IDVs) with the VA and Defense Health Agency, including Blanket Purchase Agreements (BPAs) valued up to $6.5 million, to provide radiopharmaceuticals, nuclear medicine supplies, and diagnostic imaging agents to federal healthcare providers.
Quick answers
Who was awarded contract 36C25724F0052?
36C25724F0052 was awarded to Progenics Pharmaceuticals Inc. by Veterans Integrated Service Network 17 (Veterans Health Administration) on January 2, 2024.
How much is contract 36C25724F0052 worth?
The government has obligated $1,836,004 on 36C25724F0052.
Is contract 36C25724F0052 an order under another contract?
Yes. 36C25724F0052 is a delivery order under 36F79719D0170, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C25724F0052 competed?
The extent of competition for 36C25724F0052 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award